Cargando…

Risk Factors for Development of Carbapenem Resistance Among Gram-Negative Rods

BACKGROUND: Infections due to carbapenem-resistant Gram-negative rods (CR-GNR) are increasing in frequency and result in high morbidity and mortality. Appropriate initial antibiotic therapy is necessary to reduce adverse consequences and shorten length of stay. METHODS: To determine risk factors for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Stefan E, Miller, Loren, Needleman, Jack, Uslan, Daniel Z, Bell, Douglas, Watson, Karol, Humphries, Romney, McKinnell, James A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405936/ https://www.ncbi.nlm.nih.gov/pubmed/30863785 http://dx.doi.org/10.1093/ofid/ofz027

Ejemplares similares

In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant Enterobacteriaceae
por: Patterson, Jan E, et al.
Publicado: (2019)

Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa
por: Cai, Bin, et al.
Publicado: (2017)

Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
por: Alosaimy, Sara, et al.
Publicado: (2021)

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study
por: McCann, Eilish, et al.
Publicado: (2018)

Antibiotic Treatment Failure and Associated Outcomes Among Adult Patients With Community-Acquired Pneumonia in the Outpatient Setting: A Real-world US Insurance Claims Database Study
por: Tillotson, Glenn, et al.
Publicado: (2020)

Carbapenem-Resistant Gram-Negative Fermenting and Non-Fermenting Rods Isolated from Hospital Patients in Poland—What Are They Susceptible to?
por: Brauncajs, Małgorzata, et al.
Publicado: (2022)

Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia
por: Erickson, Reaghan M, et al.
Publicado: (2019)

Epidemiology and Clinical Outcomes of Non-HACEK Gram-Negative Infective Endocarditis
por: Shah, Sunish, et al.
Publicado: (2023)

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy
por: Eilertson, Brandon, et al.
Publicado: (2017)

Is It Actionable? An Evaluation of the Rapid PCR-Based Blood Culture Identification Panel on the Management of Gram-Positive and Gram-Negative Blood Stream Infections
por: Tseng, Andrew S, et al.
Publicado: (2018)

Impact of Catheter Management on Clinical Outcome in Adult Cancer Patients With Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia
por: Chesdachai, Supavit, et al.
Publicado: (2022)

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
por: Nordmann, Patrice, et al.
Publicado: (2019)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

De Novo Daptomycin-Nonsusceptible Enterococcal Infections
por: Kelesidis, Theodoros, et al.
Publicado: (2012)

Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers
por: Castrejón, Mariana, et al.
Publicado: (2017)

The Impact of Acute Kidney Injury on the Risk of Mortality and Health Care Utilization Among Patients Treated With Polymyxins for Severe Gram-Negative Infections
por: Baradaran, Sarah, et al.
Publicado: (2018)

Gram-Negative Rods on Inanimate Surfaces of Selected Hospital Facilities and Their Nosocomial Significance
por: Zahornacký, Ondrej, et al.
Publicado: (2022)

Analysis of Gram-negative rod bacteremia in the surgical and medical ICU
por: Adukauskiene, D, et al.
Publicado: (2015)

Predictors of Readmission Following Discharge of Patients With Gram-Negative Bacteremia: A Retrospective Cohort Study
por: Porat, Yanay, et al.
Publicado: (2021)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

Effectiveness of a double-carbapenem combinations against carbapenem-resistant Gram-negative bacteria
por: Lu, Jiayue, et al.
Publicado: (2022)

Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections
por: Gavaghan, Victoria, et al.
Publicado: (2022)

Treatment of Piperacillin-Tazobactam–Nonsusceptible/Ceftriaxone-Susceptible Infections With Carbapenem Versus Carbapenem-Sparing Antimicrobials
por: Cao, John, et al.
Publicado: (2023)

Appropriateness of Gram-Negative Agent Use at a Tertiary Care Hospital in the Setting of Significant Antimicrobial Resistance
por: Vora, Neil M., et al.
Publicado: (2015)

Management of Gram-Negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact With and Without Antibiotic Stewardship
por: Claeys, Kimberly C, et al.
Publicado: (2020)

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections
por: Giannella, Maddalena, et al.
Publicado: (2019)

Epidemiology of Gram-Negative Bloodstream Infections in the United States: Results From a Cohort of 24 Hospitals
por: Ince, Dilek, et al.
Publicado: (2023)

The role of carbapenems in initial therapy for serious Gram-negative infections
por: Rahal, James J
Publicado: (2008)

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
por: Ramphal, Reuben
Publicado: (2008)

Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014)

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
por: Doi, Yohei
Publicado: (2019)

Editorial: The global threat of carbapenem-resistant gram-negative bacteria
por: Dropa, Milena, et al.
Publicado: (2022)

High Carriage Rates of Multidrug-Resistant Gram-Negative Bacteria in Neonatal Intensive Care Units From Ghana
por: Labi, Appiah-Korang, et al.
Publicado: (2020)

Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process
por: Heil, Emily L, et al.
Publicado: (2021)

Quantifying Gram-Negative Resistance to Empiric Treatment After Repeat ExpoSure To AntimicRobial Therapy (RESTART)
por: Wibisono, Arya, et al.
Publicado: (2022)

Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals
por: Goodman, Katherine E, et al.
Publicado: (2022)

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
por: Tran, Nikki N, et al.
Publicado: (2023)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
por: Wolfensberger, Aline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tdb3h54rbttpuhfp9p5t6lubq2